Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Viral macrophage inflammatory protein-II improves acute rejection in allogeneic rat kidney transplants.

Bedke J, Stojanovic T, Kiss E, Behnes CL, Proudfoot AE, Gröne HJ.

World J Urol. 2010 Aug;28(4):537-42. doi: 10.1007/s00345-010-0556-0. Epub 2010 Apr 18.

2.

Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.

Pillai RG, Beutelspacher SC, Larkin DF, George AJ.

Transplantation. 2008 Jun 15;85(11):1640-7. doi: 10.1097/TP.0b013e318172813f.

PMID:
18551072
3.

Met-RANTES inhibition of mucosal perfusion failure in acute intestinal transplant rejection - role of endothelial cell-leukocyte interaction.

Stojanovic T, Bedke J, Gröne HJ, Proudfoot AE, Becker H, Markus P, Hecker M.

J Vasc Res. 2002 Jan-Feb;39(1):51-8.

PMID:
11844937
4.

Prolonged ischemia elicits acute allograft rejection involved in CXCR3 activation in rat kidney transplants.

Zou XF, Song B, Duan JH, Hu ZD, Cui ZL, Gu C.

Transpl Immunol. 2015 Oct;33(2):103-9. doi: 10.1016/j.trim.2015.08.001. Epub 2015 Aug 22.

PMID:
26303820
5.

[Reduction of acute kidney transplantation rejection by the chemokine receptor antagonist Met-RANTES].

Gröne HJ, Weber C, Weber KS, Gröne EF, Klier CM, Wells TN, Proudfoot AE, Schlöndorff D, Nelson PJ.

Verh Dtsch Ges Pathol. 1999;83:205-11. German.

PMID:
10714211
6.

A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage.

Bedke J, Nelson PJ, Kiss E, Muenchmeier N, Rek A, Behnes CL, Gretz N, Kungl AJ, Gröne HJ.

Mol Immunol. 2010 Feb;47(5):1047-57. doi: 10.1016/j.molimm.2009.11.012. Epub 2009 Dec 11.

PMID:
20004976
7.
8.

Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection.

Kiss E, Adams J, Gröne HJ, Wagner J.

Transplantation. 2003 Aug 15;76(3):480-9.

PMID:
12923432
9.

Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection.

Le Meur Y, Jose MD, Mu W, Atkins RC, Chadban SJ.

Transplantation. 2002 Apr 27;73(8):1318-24.

PMID:
11981428
10.

Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).

Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ.

Transplantation. 2001 Jul 27;72(2):209-15.

PMID:
11477340
11.

Macrophages act as effectors of tissue damage in acute renal allograft rejection.

Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ.

Transplantation. 2003 Oct 15;76(7):1015-22.

PMID:
14557746
12.

Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.

Gröne HJ, Weber C, Weber KS, Gröne EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlöndorff D, Nelson PJ.

FASEB J. 1999 Aug;13(11):1371-83.

13.

Binding of lymphocytes to acutely rejecting rat kidney allografts in vitro is guided by events in the graft itself rather than by sensitization of host lymphocytes.

Tullius SG, Heemann UW, Zeilinger K, Azuma H, Tamatami T, Miyasaka M, Tilney NL.

Transpl Immunol. 1995 Jun;3(2):91-7.

PMID:
7582910
14.

STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplants.

Stojanovic T, Scheele L, Wagner AH, Middel P, Bedke J, Lautenschläger I, Leister I, Panzner S, Hecker M.

Gene Ther. 2007 Jun;14(11):883-90. Epub 2007 Mar 15.

PMID:
17361215
15.

Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.

Knoll T, Oltersdorf J, Göttmann U, Schaub M, Michel MS, Kirchengast M, van der Woude FJ, Rohmeiss P, Braun C.

Transpl Int. 2003 Jun;16(6):425-9. Epub 2003 Mar 26.

16.

Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine.

Shimizu A, Yamada K, Sachs DH, Colvin RB.

Lab Invest. 2002 Jun;82(6):673-86.

PMID:
12065677
17.

Anti-ICAM-1 antibodies protect allografts against microvascular and parenchymal cell damage.

Siemionow M, Demirkan F, Rockwell WB, Lister GD.

J Hand Surg Am. 1997 Sep;22(5):922-30.

PMID:
9330156
18.

In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.

Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L.

J Exp Med. 1998 Jul 6;188(1):193-8.

19.

Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.

Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P.

Transplantation. 1999 Sep 27;68(6):739-46.

PMID:
10515373
20.

Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.

Weber KS, Gröne HJ, Röcken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C.

Eur J Immunol. 2001 Aug;31(8):2458-66.

Items per page

Supplemental Content

Write to the Help Desk